Skip to main content
OpenTrials

Clinical trial condition

DLBCL

Explore clinical trials studying DLBCL. Study availability and eligibility vary by location and protocol.

51 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

DLBCL trial results

Completed

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

NCT03997968

Conditions
Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
View all 16 locations
View Trial Details
Completed

Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL

NCT05233033

Conditions
DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)

NCT03527147

Conditions
DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site New Orleans, Louisiana, United States
View Trial Details
Completed

Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers

NCT01563302

Conditions
Advanced Cancers, DLBCL, Hemic and Lymphatic Diseases, +7 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Blood and Marrow Transplant Group of Georgia at Northside Hospital Atlanta, Georgia, United States
View Trial Details

Related conditions